TeselaGen and bitBiome Collaborate to Connect AI-Driven Microbial Discovery with the Lab Bench

bitBiome adopts TeselaGen's AI-powered platform to run its strain-engineering and lab-automation workflows, linking single-cell genomic intelligence to the experiments that turn it into products

PORTOLA VALLEY, Calif. and TOKYO, Nov. 12, 2026 — TeselaGen Biotechnology Inc., the AI-powered platform for designing, building, testing and optimizing biological systems, today announced a collaboration with bitBiome, Inc., an AI-native biotechnology company transforming the world's microbial diversity into predictive biological intelligence. bitBiome has deployed the TeselaGen platform across its research teams to manage strain engineering, sample tracking and automated lab workflows, connecting the designs produced by its AI and genomic data platform to the experimental results that validate them.

bitBiome builds proprietary genomic datasets from individual microbial cells with its bit-MAP® single-cell sequencing technology. Those data feed bit-GEM, their sequence catalog, and SENS-AI, their AI model for designing and optimizing enzymes and strains. Each design still has to be built, tested and measured in the lab using their high-throughput sequence and whole genome editing platform bit-EVO, and the value of the AI grows with every result that feeds back into it. TeselaGen provides that operational layer: a single system of record for constructs, strains, samples and plates, electronic lab notebooks, and configurable workflows that carry each experiment from design to data.

TeselaGen gave us a platform our scientists could shape around their own workflows, and a team that moved at our pace," said Yuji Suzuki, CEO, bitBiome.

Post this

Over the course of 2026, TeselaGen and bitBiome teams worked together to model bitBiome's strain-engineering and automation workflows on the platform. "bitBiome is building one of the most distinctive microbial data assets in the world, and AI models are only as good as the experimental loop behind them," said Eduardo Abeliuk, Ph.D., CEO of TeselaGen. "Our job is to make that loop fast and traceable, so every strain bitBiome designs is built, tested and fed back into its models with full context. Working side by side with their team has made our platform better for every lab that runs design-build-test-learn at scale."

"Our AI platform designs enzymes and strains from our proprietary data that cannot be found in the public databases. Turning those designs into results for our partners depends largely on how efficiently we can test those designs in the lab. TeselaGen gave us a platform our scientists could shape around their own workflows, and a team that moved at our pace," said Yuji Suzuki, CEO, bitBiome.

bitBiome partners with companies including Twist Bioscience, Ajinomoto, Tojo Vikas, and Kyoritsu Seiyaku, on enzyme and strain development for life science, food, materials, animal health and other biomanufacturing applications. The TeselaGen platform supports this partnered work by giving each program a consistent, auditable record from sequence to result.

Media Contact

Eduardo Abeliuk, TeselaGen Biotechnology Inc., 1 510-761-7938, [email protected], https://teselagen.com/

Laura Shelton, bitBiome, [email protected], https://bitbiome.bio/

SOURCE TeselaGen Biotechnology Inc.